bioRxivCancer BiologyPreprint
ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: a Multi-disciplinary Team-based, Multifactorial Analytical Approach
S. K. Johnston, P. Whitmire, S. C. Massey, P. Kumthekar, A. B. Porter, N. Raghunand, L. F. Gonzalez-Cuyar, M. M. Mrugala, A. Hawkins-Daarud, P. R. Jackson, L. S. Hu, J. N. Sarkaria, L. Wang, R. A. Gatenby, K. M. Egan, P. Canoll, K. R. Swanson
Abstract
Although glioblastoma is a fatal primary brain cancer with a short median survival of 15 months, a small number of patients survive more than 5 years after diagnosis; they are known as extreme survivors (ES). Due to their rarity, very little is known about what differentiates these outliers from other glioblastoma patients. For the purpose of identifying unknown drivers of extreme survivorship in glioblastoma, we developed the ENDURES consortium (ENvironmental Dynamics Underlying Responsive Extreme Survivors of glioblastoma). This consortium is a multicenter collaborative network of investigators focused on the integration of multiple types of clinical data and the creation of patient-specific models of tumor growth informed by radiographic and histological parameters. Leveraging our combined resources, the goals of the ENDURES consortium are two-fold: (1) to build a curated, searchable, multilayered repository housing clinical and outcome data on a large cohort of ES patients with glioblastoma and (2) to leverage the ENDURES repository for new insights on tumor behavior and novel targets for prolonging survival for all glioblastoma patients. In this article, we review the available literature and discuss what is already known about ES. We then describe the creation of our consortium and some of our preliminary results.\n\nFundingThis review was financially supported by a grant from the James S. McDonnell Foundation\n\nConflicts of InterestThe authors have declared that no conflicts of interest exist.\n\nAuthorshipConceptualized consortium: LW, RG, KME, PC, and KRS. Built consortium: SKJ, PK, NR, JS, KME, PC, and KRS. Wrote the manuscript: SKJ, PW, SCM, PK, AP, and KME. Reviewed and edited the manuscript: LFGC, MMM, AHD, PRJ, and LSH. Contributed to writing, provided feedback, and approved of final manuscript: All authors.\n\nLink to website for ENDUREShttp://mathematicalneurooncology.org/?page_id=2125
- organism: human
- assay: clinical cohort / trial
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combinatorial Treatment of Glioblastoma with Temozolomide (TMZ) Plus 5-Ethynyl-2'-deoxyuridine (EdU)
Humeyra Kaanoglu, Yasemin Kübra Akyel, … Aziz Sancar·Proceedings of the National Academy of SciencesPeer-reviewed·Dec 31, 2025
- Glioma Through the Looking GLASS: the Glioma Longitudinal Analysis consortium, molecular evolution of diffuse gliomas
The Glioma Longitudinal Analysis Consortium, R. Verhaak·bioRxiv·Oct 2, 2017
- Regulation of PD1 signaling is associated with prognosis in glioblastoma multiforme
Camila M. Lopes‐Ramos, Tatiana Belova, … Marieke L. Kuijjer·Cancer ResearchPeer-reviewed·Sep 7, 2021
- Ex vivo stem-like cell families model evolution of glioblastoma therapeutic resistance
Marta Prelli, Francesca De Bacco, … Carla Boccaccio·bioRxiv·Apr 6, 2026
- Days Gained: A Simulation-Based, Response Metric in the Assessment of Glioblastoma
Gustavo De Leon, Kyle Singleton, Kristin R. Swanson·bioRxiv·Jan 7, 2018
- Histology and spatial transcriptomic integration revealed infiltration zone with specific cell composition as a prognostic hotspot in glioblastoma
Lucas Fidon, Mélanie Lubrano, … Franck Bielle·bioRxiv·Oct 8, 2025